Disease

Multiple Sclerosis

Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system with relapsing and progressive forms that can cause neurologic disability.

Coverage in progress. AssetMemo has not yet run its full census for Multiple Sclerosis Exacerbations, Secondary Progressive Multiple Sclerosis, so the assets listed for them are not complete.

Combined attributable cost

$65.6B+

Drug spend

$35.2B+

How this is calculated ↗

54% of total cost is drugs

Sum of 3 indications below.

All assets in Multiple Sclerosis

← Neurology